Mohammad Hashim Mustehsan

Mohammad Hashim Mustehsan practices at Rhode Island Hospital/Hasbro Children's in Providence, Rhode Island.

Mohammad Hashim Mustehsan's NPI, 1013449057, was assigned on March 29, 2017. Mohammad Hashim Mustehsan holds Rhode Island license MD19961.

Mohammad Hashim Mustehsan's primary practice is Rhode Island Hospital/Hasbro Children's, at 593 Eddy St, Providence, RI 02903 in Providence County. The practice phone is (401) 444-6966.

Mohammad Hashim Mustehsan's primary practice is Rhode Island Hospital/Hasbro Children's in Providence, Rhode Island. Mohammad Hashim Mustehsan is also affiliated with Brigham and Women's Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Mohammad Hashim Mustehsan to 4 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mohammad Hashim Mustehsan practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Mohammad Hashim Mustehsan's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Mohammad Hashim Mustehsan's licenses on file in 2 states: Rhode Island and Massachusetts.

CMS data shows 32 Medicare services from Mohammad Hashim Mustehsan across 2 procedure codes in 2024, for 27 Medicare patients. Medicare paid $2,823 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Mohammad Hashim Mustehsan in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mohammad Hashim Mustehsan's median patient age at 74, with 43% women.

In 2024, Mohammad Hashim Mustehsan wrote 128 Medicare Part D claims for 30 patients. 79% of them were for generic drugs. CMS names the drug for 68 of them, across 4 drugs with 11 or more claims each, at $16,576 in total drug cost. In 2023, CMS named 433 claims across 14 drugs.

Mohammad Hashim Mustehsan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mohammad Hashim Mustehsan as offering telehealth. CMS counts 83 procedures of coronary angioplasty and stenting by Mohammad Hashim Mustehsan, more than 94% of the clinicians it reports for that procedure.

CMS Open Payments shows 51 general payments to Mohammad Hashim Mustehsan from 5 drug and device companies from 2024 to 2025. Grants make up the largest share, 85% of the total. Medtronic, Inc. paid the most, $26,840.